Acute encephalopathy with biphasic seizures and late reduced diffusion in Kawasaki disease

Takeshi Shiba1,2, Keigo Hamahata2, Akira Yoshida2

  • 1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Shogoin, Sakyo, Kyoto.

Insights

Kawasaki disease (KD) can lead to acute encephalopathy with biphasic seizures and late reduced diffusion (AESD), a serious neurological complication. This case highlights AESD as a rare but severe outcome in infants with KD.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Neuroimaging

Background:

  • Kawasaki disease (KD) is a critical pediatric illness.
  • Neurological complications of KD are not fully understood.
  • Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a severe neurological condition.

Observation:

  • A 7-month-old infant with Kawasaki disease presented with fever, status epilepticus, and cluster seizures.
  • Neurological deterioration included severe disturbance of consciousness.
  • Diffusion-weighted MRI revealed diffuse high signals in bilateral subcortical white matter.

Findings:

  • Electroencephalogram showed low-voltage slow waves, indicative of significant brain dysfunction.
  • The clinical and imaging findings were consistent with acute encephalopathy with biphasic seizures and late reduced diffusion (AESD).
  • This represents the first reported instance of AESD complicating Kawasaki disease.

Implications:

  • This case expands the spectrum of neurological complications associated with Kawasaki disease.
  • AESD in KD patients can lead to severe and persistent neurological sequelae.
  • Early recognition and management of neurological complications in KD are crucial.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
711
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K